Plasma Amino Acid Levels After Protein Ingestion or Amino Acid Injection During Dialysis

End Stage Renal Disease on Dialysis (Diagnosis) Clinical Trial

Official title:
Prospective, Monocentric, Open-label, Randomized Study Comparing Intradialytic Plasma Kinetics of Amino Acids After Administration Per os of Renoral® and Intravenous Administration of Amino Acids.

Status Recruiting

Clinical Trial Summary

The aim of the study is to compare intradialytic plasma kinetics of amino acids after administration per os of Renoral or intravenous administration of amino acids in patients with end-stage renal disease treated with hemodialysis maintenance.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

End Stage Renal Disease on Dialysis (Diagnosis)
Kidney Failure, Chronic

Clinical Trial Details

NCT number	NCT03807583
Study type	Interventional
Source	Indigo Therapeutics
Contact	RAYMOND AZAR, MD
Phone	+333 28 28 53 28
Email	Raymond.Azar@ch-dunkerque.fr
Status	Recruiting
Phase	N/A
Start date	March 15, 2019
Completion date	July 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03629496` - Developing an Arts-based Intervention for Patients With End-stage Kidney Disease Whilst Receiving Haemodialysis	N/A
Completed	`NCT03459807` - Blood Pressure Lowering in Dialysis (BOLD) Trial	Phase 2
Not yet recruiting	`NCT03733262` - Targeted Deprescribing in Patients on Hemodialysis
Withdrawn	`NCT03523260` - Comparison of High-Flow Hemodialysis Catheters Placed From the Left Internal Jugular Vein(R12-022)	N/A
Active, not recruiting	`NCT03934736` - HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis	Phase 1